Long-term safety of dichloroacetate in congenital lactic acidosis
- 1 June 2013
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 109 (2) , 139-143
Abstract
No abstract availableKeywords
Funding Information
- University of Florida Clinical and Translational Science Institute
- NIH/NCATS Clinical and Translational Science Award to the University of Florida (UL1 TR000064)
This publication has 32 references indexed in Scilit:
- The spectrum of pyruvate dehydrogenase complex deficiency: Clinical, biochemical and genetic features in 371 patientsMolecular Genetics and Metabolism, 2012
- The Dichloroacetate Dilemma: Environmental Hazard versus Therapeutic Goldmine—Both or Neither?Environmental Health Perspectives, 2011
- Metabolic acidosis: pathophysiology, diagnosis and managementNature Reviews Nephrology, 2010
- Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicityJournal of Neurochemistry, 2010
- Peripheral Neuropathy in Rats Exposed to DichloroacetateJournal of Neuropathology & Experimental Neurology, 2009
- Polymorphisms in the human glutathione transferase zeta promoterPharmacogenetics and Genomics, 2006
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001
- Development of an Oral Drug Formulation for Dichloroacetate and ThiamineDrug Development and Industrial Pharmacy, 1994
- Treatment of Lactic AcidosisNew England Journal of Medicine, 1984
- Dichloroacetate as Treatment for Congenital Lactic AcidosisNew England Journal of Medicine, 1978